The FDA's Gene-Therapy Reversal and the Exit of Vinay Prasad
WSJ Opinion: Potomac Watch
00:00
Navigating FDA Approval Dilemmas
This chapter explores the complex debate surrounding the FDA's drug approval processes in light of the 'right to try' movement and recent leadership changes. It delves into the balance between ensuring patient access to innovative treatments and maintaining rigorous safety standards, particularly in cases of gene therapy and rare diseases.
Transcript
Play full episode
